A Randomized Parallel, Masked to Evaluate the Efficacy of Triamcinolone Associated With Nepafenac (Nevanac) Compared With Intravitreal Injection of Triamcinolone for Treatment of Clinically Significant Diabetic Macular Edema.
Phase of Trial: Phase III
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Nepafenac (Primary) ; Triamcinolone
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 19 Mar 2018 Status changed from active, no longer recruiting to completed.
- 15 Nov 2008 New trial record.